LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1235 | 2032 | 3974 | 0.5113 | 0.3434 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1235 | 1884 | 4070 | 0.4629 | 0.2780 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1235 | 1989 | 4126 | 0.4820 | 0.3149 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1235 | 1928 | 3974 | 0.4851 | 0.3022 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1235 | 1901 | 4070 | 0.4670 | 0.2847 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1235 | 1883 | 4126 | 0.4563 | 0.2741 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1235 | 1859 | 3974 | 0.4678 | 0.2743 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1235 | 1866 | 4070 | 0.4584 | 0.2709 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1235 | 2111 | 4126 | 0.5116 | 0.3606 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1235 | 1556 | 3974 | 0.3915 | 0.1467 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1235 | 1747 | 4070 | 0.4292 | 0.2232 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1235 | 1925 | 4126 | 0.4665 | 0.2904 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1235 | 2970 | 4119 | 0.7210 | 0.6568 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1235 | 3703 | 4356 | 0.8500 | 0.8290 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1235 | 3058 | 4326 | 0.7068 | 0.6508 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1235 | 3415 | 4119 | 0.8290 | 0.7954 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1235 | 3145 | 4356 | 0.7220 | 0.6719 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1235 | 3245 | 4326 | 0.7500 | 0.7059 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1235 | 2435 | 4119 | 0.5911 | 0.4778 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 1235 | 2497 | 4356 | 0.5732 | 0.4726 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 1235 | 2272 | 4326 | 0.5251 | 0.4007 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 1235 | 2235 | 4119 | 0.5426 | 0.4067 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 1235 | 2082 | 4356 | 0.4779 | 0.3325 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 1235 | 2437 | 4326 | 0.5633 | 0.4560 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1235 | 1988 | 4119 | 0.4826 | 0.3150 |